Propel Bio Management, LLC is an SEC-registered investment adviser based in Los Angeles, CA that reports managing 1 hedge fund on Form ADV. It reports $247.5 million in regulatory assets under management. Its private funds, of all types, hold $172.2 million in gross assets. Its disclosed U.S. stock holdings returned an estimated +14.0% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated -13.7% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $247.5 millionForm ADV Item 5.F
- Gross assets of private funds
- $172.2 millionAll private fund types, Form ADV
- Hedge funds managed
- 14 private funds in total
- Employees
- 7Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 322858
- Latest Form ADV
- 03/23/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +25.3% | +14.8% |
| Q1 2026 | -9.0% | -4.6% |
| Q4 2025 | -0.6% | +2.4% |
| Q3 2025 | +11.2% | +7.8% |
| Q2 2025 | +2.7% | +10.4% |
| Q1 2025 | -4.8% | -4.5% |
| Q4 2024 | -40.2% | +2.1% |
| Q3 2024 | +17.1% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Largest disclosed holdings
- Plains GP Hldgs L P LTD Partnr$30.9 million
- Achieve Life Sciences Inc$26.3 million
- Corcept Therapeutics Inc$11.9 million
- Phathom Pharmaceuticals Inc$11.4 million
- Delcath SYS Inc$11.0 million
- Milestone Pharmaceuticals Inc$10.0 million
- Compass Pathways PLC$8.1 million
- Kyverna Therapeutics Inc$7.9 million
- Artiva Biotherapeutics Inc$6.8 million
- Abeona Therapeutics Inc New$6.1 million
As of 2026-06-30, from 13F filing by Propel Bio Management, LLC.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. HedgeMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures